MicroRNAs in hematological malignancies: A novel approach to targeted therapy

Hematology

Volumn 17, Issue 3, 2012, Pages 170-175

  Joshi, Dolly ^a   Gosh, Kanjaksha ^a   Vundinti, Babu Rao ^a  

^a KEM HOSPITAL   (India)

Author keywords

Antagomirs; Hematological malignancies; miRNA; miRNA masking; miRNA sponges; Profiling; Targeted therapy

Indexed keywords

ANTAGOMIR; ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA SPONGE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DRUG RESEARCH; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; LEUKEMOGENESIS; MOLECULARLY TARGETED THERAPY; ONCOGENE; PRIORITY JOURNAL; RNA BINDING; RNA INTERFERENCE; RNA PROCESSING; RNA SYNTHESIS; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL PROLIFERATION; HEMATOLOGIC NEOPLASMS; HEMATOPOIESIS; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE;

EID: 84863084610     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453312X13376952196656     Document Type: Article

References (45)

1. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM. MicroRNA expression and function in cancer. Trends in molecular medicine. Review. 2006;12(12):580-587.
2. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. Genomics. 2007;8:166.
3. Nelson P, Kiriakidou M, Sharma A, Maniataki E, Mourelatos Z. The microRNA world: small is mighty. Biochem. Sci. 2003; 28(10):534-540.
4. Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science. 1999;286: 950-952.
5. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 2001; 15:188-200.
6. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L, et al. MiRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002;16:720-728.
7. Albano F, Anelli L, Zagaria A, Liso V, Rocchi M, Specchia G. MIRN 199B downregulation in chronic myeloid leukaemia is associated with deletions on der (9). Br J Haematol. 2008;144: 263-375.
8. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J. Pathol. 2011;223:102-115.
9. Griffiths JS, Saini HK, van Dongen S, Enright AJ. MiRBase: tools for microRNA genomics. Nucleic Acid Res. 2008;36: D154-D158.
10. Dong C, Ji M, Ji C. McroRNAs and their potential target genes in leukemia pathogenesis. Cancer Biol. Therapy. 2009;8(3): 200-205.
11. Huppi K, Volfovsky N, Mackiewicz M, Runfola T, Jones TL, Martin SE, et al. MicroRNAs and genomic instability. Semin Cancer Biol. 2007;17:65-73.
12. Navarro F, Lieberman J. Small RNAs guide hematopoietic cell differentiation and function. J Immunol. 2010;184:5939-5947.
13. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell. Biol. 2005;6:376-385.
14. Cullen BR. Transcription and processing of human microRNA precursors. Mol Cell. 2004;16:861-865.
15. Pelosi E, Labbaye C, Testa U. MicroRNAs in normal and malignant myelopoiesis. Leuk Res. 2009;33:1584-1593.
16. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-297.
17. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science. 2004; 303:83-86.
18. Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Manero GG, Calin GA. MicroRNAs and noncoding RNAs in haematological malignancies: molecular, clinical and therapeutic implications. Leukemia. 2008;22:1095-1105.
19. Monticelli S, Ansel KM, Xiao C, Socci ND, Krichevsky AM, Thai TH, et al. MicroRNA profiling of the murine hematopoietic system. Genome Biology. 2005;6(8):R71.
20. Georgantas RW, III, Hildreth R, Morisot S, Alder J, Liu C, Heimfeld S, et al. CD34+ hematopoietic stem progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA. 2007;104: 2750-2755.
21. Fontana L, Pelosi E, Greco P, Racanicchi S, Testa U, Liuzzi F, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol. 2007;9:775-787.
22. Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA. 2006;103: 5078-5083.
23. Kluiver J, Kroesen BJ, Poppema S, van den Berg A. The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia. 2006;20:1931-1936.
24. Croce CM. Oncogenes and cancer. N Engl J Med. 2008;358: 502-511.
25. Calin GA, Croce CM. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest. 2007;117(8):2059-2066.
26. Manikandan J, Aarthi JJ, Srinivasan DK, Pushparaj PN. Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation. 2008;2(8):330-334.
27. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343:1910-1916.
28. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA. 2005;102:13944-13949.
29. Venturini L, Battmer K, Castoldi M, Schultheis B, Hochhaus A, Muckenthaler MU, et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood. 2007;109:4399-4405
30. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva-Jr WA, et al. MiRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res. 2007;40(11):1435-1440.
31. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341(14):1051-1062.
32. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, et al. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA. 2008;105:5166-5171.
33. Marton S, Garcia MR, Robello C, Persson H, Trajtenberg F, Pritsch O, et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia. 2008;22:330-338.
34. Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V, et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006;66(26):11590-11593.
35. Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP, et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by upregulation of genes involved in stemcell maintenance. Blood. 2005;106:899-902.
36. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008;9:405-414.
37. Bueno MJ, Perez de Castro I, Gomez de Cedron M, Santos J, Calin GA, Cigudosa JC, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 2008;13:496-506.
38. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, et al. An oligonucleotide microchip for genomewide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci USA. 2004;101(26):9740-9744.
39. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838.
40. Friedländer MR, Chen W, Adamidi C, Maaskola J, Einspanier R, Knespel S, et al. Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol. 2008;26:407-415.
41. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-866.
42. Soifer HS, Rossi JJ, Saetrom P. MicroRNAs in disease and potential therapeutic applications. Mol Therapy. 2007;15(12): 2070-2079.
43. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr Biol. 2010;20(19):858-861.
44. Choi WY, Giraldez AJ, Schier AF. Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430. Science. 2007;318:271-274.
45. Xiao J, Yang B, Lin H, Lu Y, Luo X, Wang Z. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4. J Cell Physiol. 2007;212(2):285-292.